valproic acid has been researched along with Epilepsy Progressive Myoclonic 2 in 2 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corkill, RG | 1 |
| Hardie, RJ | 1 |
| Verrotti, A | 1 |
| Trotta, D | 1 |
| Di Corcia, G | 1 |
| Blasetti, A | 1 |
| Cutarella, R | 1 |
| Basciani, F | 1 |
| Chiarelli, F | 1 |
2 other studies available for valproic acid and Epilepsy Progressive Myoclonic 2
| Article | Year |
|---|---|
An unusual case of Lafora body disease.
Topics: Adolescent; Cerebral Cortex; Electroencephalography; Fatal Outcome; Humans; Lafora Disease; Male; St | 1999 |
[Lafora's disease: one of the causes for drug-resistant epilepsy in adolescence].
Topics: Adolescent; Age Factors; Anticonvulsants; Carbamazepine; Child; Drug Resistance; Drug Therapy, Combi | 2001 |